ESC Premium Access

After peripheral endovascular therapy, DAPT remains the preferred option over dual-pathway antithrombotic therapy: con.

Congress Session

About the speaker

Professor Marianne Brodmann

Medical University of Graz, Graz (Austria)
6 presentations
0 follower

2 more presentations in this session

After peripheral endovascular therapy, DAPT remains the preferred option over dual-pathway antithrombotic therapy: pro.

Speaker: Professor C. Heiss (Guildford, GB)

Thumbnail

Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy? – discussion.

Speaker: Professor I. Baumgartner (Bern, CH)

Thumbnail

Access the full session

Great Debate: antithrombotic therapeutic dilemmas in PAD – dual antiplatelet or dual-pathway antithrombotic therapy?

Speakers: Professor M. Brodmann, Professor C. Heiss, Professor I. Baumgartner
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

The digital patient is here - let's discuss

22 October 2021

ESC Premium Access

Digital health: patient perspectives

22 October 2021

ESC Premium Access

The ESC journey and future directions.

22 October 2021

This platform is supported by

logo Novo Nordisk